Clinical Decision Support System for Treatment and Management strategies of COPD
DOI:
https://doi.org/10.26438/ijcse/v10i2.3134Keywords:
COPD, CDSS, Treatment & Management strategiesAbstract
n this advanced technology most of the modern hospitals are adopting Clinical Decision Support System (CDSS) model for the diagnosis and management of most of the medical related problems. The system plays a vital role in medical decisions. In the present study, we are developing a CDSS which helps the physician to take better medical decision on the diagnosis of Chronic Obstructive Pulmonary Disease (COPD). The system also helps to take appropriate decision on treatment and management strategies for patients who are suffering from COPD. COPD is an increased inflammatory immune response to the lungs to particles and gases, from cigarette smoke, neutrophils. COPD is considered as a long term dysfunction, disease but its natural history as it occurs at intervals by periods of acute deterioration or exacerbations. Patients with COPD can have a sign of relief and be positive in today’s generation because new medical therapies with alternate remedies. Any disease requires well-planned management strategies. In this paper we have designed a CDSS for treatment and management for COPD.
References
[1] World Health Statistics, World Health Organization, 2009.
[2] S. Anakal and P. Sandhya, "Clinical decision support system for chronic obstructive pulmonary disease using machine learning techniques," 2017. International Conference on Electrical, Electronics, Communication, Computer, and Optimization Techniques (ICEECCOT), 2017, pp. 1-5, doi:10.1109/ICEECCOT.2017.8284601.
[3] S. Beom Choi, J. S. Park, J. W. Chung, T. K. Yoo and D. W. Kim, "Multicategory classification of 11 neuromuscular diseases based on microarray data using support vector machine," 2014 36th Annual nternational Conference of the IEEE Engineering in Medicine and Biology Society, 2014, pp. 3460-3463, doi: 10.1109/EMBC.2014.6944367.
[4] L. M Fabrri, S. S Hurd, for the GOLD scientific committee.
[5] B Gooptu, UI Ekeowa, DA Lomas, "Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights", Eur Respir J. 2009 Aug;34(2):475-88.
[6] BA Forey, AJ Thornton, PN Lee, "Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and Emphysema", BMC Pulm Med 2011;11:36
[7] Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. "An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease", Am J Respir Crit Care Med 2010; 182: 693-718.
[8] Coultas D104. B, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD 2007; 4: 23-8.
[9] The Global Burden of Disease, World Health Organization. 180. 2004
[10]Vipul Kashyapa, Alfredo Moralesb, Tonya Hongsermeiera, “On Implementing Clinical Decision Support: Achieving Scalability and Maintainability by Combining Business Rules and Ontologies”.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit and that in the event of reuse or distribution, the terms of this license are made clear.
